Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, May 8, 2023
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
[ Mon, May 08th 2023
] - WOPRAI
Etzer Darout Initiated (ACRV) at Buy and Held Target at $25 on, May 8th, 2023
Etzer Darout of BMO Capital, Initiated "Acrivon Therapeutics, Inc." (ACRV) at Buy and Held Target at $25 on, May 8th, 2023.
Etzer has made no other calls on ACRV in the last 4 months.
There is 1 other peer that has a rating on ACRV. Out of the 1 peers that are also analyzing ACRV, 0 agree with Etzer's Rating of Hold.
This is the rating of the analyst that currently disagrees with Etzer
- Emily Bodnar of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $24 on, Tuesday, May 2nd, 2023
